相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Magnetically controlled capsule endoscopy as a non-invasive tool for risk stratification of gastroesophageal varices in compensated cirrhosis (CHESS1801): A prospective multicenter study
Shuai Wang et al.
JOURNAL OF HEPATOLOGY (2019)
Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancer
Fabio Barra et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations
Rajmohan Murali et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2019)
Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade)
Naveena Singh et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2019)
A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients
D. Beck et al.
LEUKEMIA (2018)
Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma
Shaomin Hu et al.
MODERN PATHOLOGY (2018)
A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma
Meng Zhou et al.
BMC CANCER (2018)
Cancer incidence and mortality in China, 2014
Wanqing Chen et al.
CHINESE JOURNAL OF CANCER RESEARCH (2018)
A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K/mTOR Dual Inhibitor, in Patients with Advanced Cancer
Johanna C. Bendell et al.
CLINICAL CANCER RESEARCH (2018)
A MicroRNA Signature Associated With Metastasis of T1 Colorectal Cancers to Lymph Nodes
Tsuyoshi Ozawa et al.
GASTROENTEROLOGY (2018)
Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
Mana Taki et al.
NATURE COMMUNICATIONS (2018)
PAN-cancer analysis of S-phase enriched IncRNAs identifies oncogenic drivers and biomarkers
Mohamad Moustafa Ali et al.
NATURE COMMUNICATIONS (2018)
Crosstalk between PKCα and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium
Alice H. Hsu et al.
CELL REPORTS (2018)
LRIG2 is a growth suppressor of Hec-1A and Ishikawa endometrial adenocarcinoma cells by regulating PI3K/AKT- and EGFR-mediated apoptosis and cell-cycle
Dae-Shik Suh et al.
ONCOGENESIS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Clinicopathological and survival analysis of uterine papillary serous carcinoma: a single institutional review of 106 cases
Yao Wang et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Epigenetic changes as prognostic predictors in endometrial carcinomas
Sanja A. Farkas et al.
EPIGENETICS (2017)
Factors prognostic of survival in advanced-stage uterine serous carcinoma
Laura L. Holman et al.
GYNECOLOGIC ONCOLOGY (2017)
Distinct molecular landscapes between endometrioid and nonendometrioid uterine carcinomas
Nathaniel L. Jones et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
PI3K Inhibitors Synergize with FGFR Inhibitors to Enhance Antitumor Responses in FGFR2mutant Endometrial Cancers
Leisl M. Packer et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth
Ningning Zhang et al.
CELL DEATH & DISEASE (2017)
Uterine Serous Carcinomas Frequently Metastasize to the Fallopian Tube and Can Mimic Serous Tubal Intraepithelial Carcinoma
Friedrich Kommoss et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Transcriptional Addiction in Cancer
James E. Bradner et al.
CELL (2017)
Sox9 overexpression in uterine epithelia induces endometrial gland hyperplasia
Gabriel Gonzalez et al.
DIFFERENTIATION (2016)
Uterine Papillary Serous Carcinoma A Single-Institution Review of 62 Cases
Carin Black et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Clinical Significance of Positive Pelvic Washings in Uterine Papillary Serous Carcinoma Confined to an Endometrial Polyp
Krisztina Z. Hanley et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2016)
Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study
Marina Bagnoli et al.
LANCET ONCOLOGY (2016)
Analysis of clinical and pathological characteristics, treatment methods, survival, and prognosis of uterine papillary serous carcinoma
Ulas Solmaz et al.
TUMORI (2016)
Analysis of clinical and pathological characteristics, treatment methods, survival, and prognosis of uterine papillary serous carcinoma
Ulas Solmaz et al.
TUMORI (2016)
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies
Brian Rini et al.
LANCET ONCOLOGY (2015)
A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival
Fredrik Baecklund et al.
BMC MEDICAL GENETICS (2014)
LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma
Jiagen Li et al.
GUT (2014)
Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer
Jonathan D. Black et al.
WOMENS HEALTH (2014)
Early stage uterine serous carcinoma: Management updates and genomic advances
Amanda Nickles Fader et al.
GYNECOLOGIC ONCOLOGY (2013)
Clinical and Pathologic Characteristics of Serous Carcinoma Confined to the Endometrium: A Multi-institutional Study
Assaad Semaan et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2013)
A Prognostic DNA Methylation Signature for Stage I Non-Small-Cell Lung Cancer
Juan Sandoval et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Transcriptional Up-Regulation of Sox9 by NF-κB in Endometrial Carcinoma Cells, Modulating Cell Proliferation Through Alteration in the p14ARF/p53/p21WAF1 Pathway
Makoto Saegusa et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Uterine papillary serous cancer: A review of the literature
Marcela G. del Carmen et al.
GYNECOLOGIC ONCOLOGY (2012)
Uterine papillary serous carcinoma: epidemiology, pathogenesis and management
Amanda Nickles Fader et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2010)
Survival prediction of gastric cancer by a seven-microRNA signature
Xiaohua Li et al.
GUT (2010)
Expression profiling of 22 genes involved in the PI3K-AKT pathway identifies two subgroups of high-grade endometrial carcinomas with different molecular alterations
Lluis Catasus et al.
MODERN PATHOLOGY (2010)
Utility of p16 Expression for Distinction of Uterine Serous Carcinomas From Endometrial Endometrioid and Endocervical Adenocarcinomas Immunohistochemical Analysis of 201 Cases
Anna Yemelyanova et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Prostaglandin F2α-F-Prostanoid Receptor Signaling Promotes Neutrophil Chemotaxis via Chemokine (C-X-C Motif) Ligand 1 in Endometrial Adenocarcinoma
Alison E. Wallace et al.
CANCER RESEARCH (2009)
An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)
Amanda Nickles Fader et al.
GYNECOLOGIC ONCOLOGY (2009)
Transtubal spread of serous adenocarcinoma of the endometrium: An underrecognized mechanism of metastasis
MJ Snyder et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2006)
Minimal uterine serous carcinoma: a clinicopathological study of 40 cases
P Hui et al.
MODERN PATHOLOGY (2005)
Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases
BM Slomovitz et al.
GYNECOLOGIC ONCOLOGY (2003)
分享论文
